Structure-based design of novel guanidine/benzamidine mimics: Potent and orally bioavailable factor Xa inhibitors as novel anticoagulants
As part of an ongoing effort to prepare orally active factor Xa inhibitors using structure-based drug design techniques and molecular recognition principles, a systematic study has been performed on the pharmacokinetic profile resulting from replacing the
Lam, Patrick Y. S.,Clark, Charles G.,Li, Renhua,Pinto, Donald J. P.,Orwat, Michael J.,Galemmo, Robert A.,Fevig, John M.,Teleha, Christopher A.,Alexander, Richard S.,Smallwood, Angela M.,Rossi, Karen A.,Wright, Matthew R.,Bai, Stephen A.,He, Kan,Luettgen, Joseph M.,Wong, Pancras C.,Knabb, Robert M.,Wexler, Ruth R.
p. 4405 - 4418
(2007/10/03)
More Articles about upstream products of 709654-64-8
Get Best Price for709654-64-81H-Pyrazole-5-carboxamide,
1-(3-amino-1H-indazol-5-yl)-N-[2'-[[(1,1-dimethylethyl)amino]sulfonyl][1,
1'-biphenyl]-4-yl]-3-methyl-